For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Immune Modulator

Ovagen

Also known as: EDL, Glu-Asp-Leu

Research use only · not FDA-approved

Ovagen is a synthetic tripeptide (Glu-Asp-Leu, EDL) short-peptide bioregulator developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, marketed as a liver/gastrointestinal bioregulator. The Khavinson group reports it modulates gene expression in hepatocytes and GI mucosal epithelium via direct peptide-DNA interaction, with proposed effects on protein synthesis and hepatocellular repair. Evidence is limited to single-group preclinical and small clinical work; it is not FDA-approved and lacks independent Western validation. Reported CAS numbers conflict across sources, so no CAS Registry Number is asserted here.

Where to buy · live market data

Who's worth your money for Ovagen

Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.

Top Merit pick

Highest Merit Score (96) of 2 scored sellers

$4.00/mg

$79.97 · 20mg · 99.7% purity

3 COAs
Buy code MERIT · 15% off

Best value

Lowest $/mg among scored sellers

$2.75/mg

$55.00 · 20mg

no COAs yet

Average price

$3.09/mg

Sellers

7

45-day trend

-2.6%

7 of 7 sellers have a current price· 5 unverified hidden

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Watch Ovagen

Get one email when the market actually moves — no newsletter, no noise.

Compound reference

About Ovagen

CAS

Molecular formula

C15H25N3O8

Sequence

EDL

Typical dose range

No established clinical dosing; vendor research protocols commonly cite 1-2 mg/day subcutaneous or sublingual

Half-life

Not characterized in peer-reviewed pharmacokinetic literature; short-peptide bioregulators are presumed to clear rapidly (minutes)

Common research uses

liver and hepatocyte gene-regulation research (research only)gastrointestinal mucosa and liver-gut axis models (preclinical)hepatic aging and cytoprotection studies (single-group research)

Safety notes

Not FDA-approved for human therapeutic use. A Russian/Khavinson research peptide with little independent Western safety or efficacy data; sold grey-market for research use only. Not evaluated by WADA.

Reconstitution

Reconstitute lyophilized powder with bacteriostatic water; refrigerate after reconstitution.

Research depth

12 citations indexed for Ovagen

All research on Ovagen →

animal · 2025

A Novel Method to Sterilize Isolators for the Housing of Germ-Free Birds and Production of Germ-Free Eggs

Introduction The effective sterilization of isolators prior to placement of germ-free birds/eggs is crucial to ensuring that the environment is free of potential contaminants.

Study · 2025

Cone-Beam Computed Tomography Influences the Classification and Choice of Treatment for Distal Radius Fractures

Background and Purposes The objectives of this study were to investigate the inter- and intraobserver agreement in the classification of distal radius fractures (DRFs) according to the AO and the Buttazzoni classification system, for the two different radiology modalities: conventional radiography (CR) and cone-beam co…

review · 2024

40 years of AETE: the contribution of scientists and practitioners to the progress of reproductive biotechnologies in Europe

This conference celebrates the 40th anniversary of AETE. Over the past 40 years, AETE has served as a forum for scientists, practitioners, and students working in assisted animal reproduction in livestock species.

Study · 2024

Evaluation of Quality of Life, Anxiety, and Depression in Patients with Primary Axillary Hyperhidrosis Undergoing Treatment with a Microwave Device: One-year Follow-up

Hyperhidrosis is associated with social and emotional stress, affecting quality of life. Microwave energy technology treats primary axillary hyperhidrosis by thermolysis of sweat glands.

Study · 2022

Towards better process management in wastewater treatment plants: Process analytics based on SHAP values for tree-based machine learning methods

Understanding the mechanisms of pollutant removal in Wastewater Treatment Plants (WWTPs) is crucial for controlling effluent quality efficiently.

case-report · 2022

Primary malignant melanoma of the esophagus

We report a case of primary malignant melanoma of the esophagus.

Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.